Karen Smith
Director/Board Member at EMYRIA LIMITED
Net worth: 219 745 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Martin | M | 52 | 31 years | |
| Robert Foster | M | 65 | 31 years | |
| Peter Greenleaf | M | 54 | 6 years | |
| H. Parker | F | 68 | 10 years | |
| Stephen Robertson | M | 42 | 10 years | |
| Laura Shawver | M | 66 |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Philip Low | M | 76 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | 2 years |
| Michael Winlo | M | - | 5 years | |
| Alexander Macrae | M | 61 | 8 years | |
| Daniel Billen | M | 70 | 5 years | |
| Simon Read | M | - |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | - |
| Aaron Rosenberg | M | - | 3 years | |
| Prathyusha Durabaibu | F | 46 | 5 years | |
| Stewart A. Low | M | - |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | - |
| June Bray | F | 70 | 2 years | |
| Margaret Somerville | F | - | - | |
| John Markels | M | 58 | 4 years | |
| James Meyers | M | 59 | 5 years | |
| Scott Willoughby | M | - | - | |
| Lexi O’Halloran | F | - | - | |
| Kimberly McCutcheon Jablonski | F | - | 21 years | |
| Louise Wilkie | F | - | 4 years | |
| Haig Aghajanian | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | 2 years |
| Karen Smith | F | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Phillip Ramsey | M | - | - | |
| Gregory Davis | M | - | 4 years | |
| Sandy Mong | M | - |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | - |
| Brinda Balakrishnan | M | 44 | 3 years | |
| Linda Bain | F | 53 |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | 1 years |
| Daniel Hasler | M | 66 |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | - |
| Robert Carey | M | 65 | 8 years | |
| Jill Leversage | F | 67 | 5 years | |
| Jeffrey Bailey | M | 62 | 1 years | |
| Jon Filderman | M | - | 3 years | |
| Helen Torley | M | 61 | 8 years | |
| Rita Karachun | F | 63 | 3 years | |
| R. MacKay-Dunn | M | 73 | 5 years | |
| Greg Hutchinson | M | - | 1 years | |
| Duncan Moore | M | 65 | 8 years | |
| David Jaynee | M | 67 | 9 years | |
| Simon Read | M | 53 |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | 3 years |
| Kenneth Hillan | M | 63 | 4 years | |
| Mary Ann Rennie | F | - | - | |
| Tracie Ernenwein | F | - | - | |
| Amy Pooler | F | - | - | |
| Joseph Miller | M | 50 | 4 years | |
| Jerome Mychalowych | M | - | 3 years | |
| Jamie Bernard | M | - | 4 years | |
| Tim Power | M | - | 18 years | |
| Lisa Wyman | F | - | 5 years | |
| Haley Chartres | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert F. Apple | M | 58 | 16 years | |
| Christopher Lowe | M | 56 | 3 years | |
| James Hindman | M | 63 | 31 years | |
| Jeffrey Edwards | M | 64 | 22 years | |
| Peter J. Graham | M | 57 | 7 years | |
| Steven R. Deitcher | M | 59 |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | - |
| Joseph Zakrzewski | M | 60 | 11 years | |
| James Cornelius | M | 81 | 10 years | |
| Peter R. Dolan | M | 68 | 18 years | |
| Leonard S. Jacob | M | 75 | 15 years | |
| Caryn McDowell | F | 54 | 2 years | |
| David Pyott | M | 70 | 17 years | |
| John Quisel | M | 53 | 14 years | |
| Gary Loeb | M | 54 | 2 years | |
| Jacques Gonella | M | 82 | 18 years | |
| Vivid Sehgal | M | 56 | 8 years | |
| Habib Dable | M | 54 | 5 years | |
| Ambrose Bailey | M | 60 | - | |
| Herb Boyer | M | 87 | 19 years | |
| Kathy Yi | F | 52 | 2 years | |
| Francois Nader | M | 67 | 7 years | |
| Ted Monohon | M | 58 | 4 years | |
| Michael Holmes | M | - | 17 years | |
| R. Ramelmeier | M | 62 | 5 years | |
| Rosemary Crane | F | 64 | 20 years | |
| John Tsai | M | 57 | 11 years | |
| Thomas McCourt | M | 66 | 5 years | |
| Laura Hamill | F | 60 | 1 years | |
| Douglas Manion | M | 64 | 11 years | |
| David Berk | M | 45 | 6 years | |
| Gerald Bruce | M | 68 | 8 years | |
| George Golumbeski | M | 67 | 7 years | |
| Richard Pops | M | 62 | 15 years | |
| Harrison Bains | M | 80 | 16 years | |
| Louis J. Freeh | M | 74 | 8 years | |
| Timothy Meeker | M | 77 | 13 years | |
| Robert Williams | M | 75 | 7 years | |
| Heather Turner | F | 51 | 1 years | |
| Louis Gerstner | M | - | - | |
| Vicki Sato | M | 75 | 15 years | |
| Kemal Malik | M | 61 | - | |
| Roger Jeffs | M | 62 | 2 years | |
| Jean George | F | 66 | 15 years | |
| Steven Mento | M | 72 | 14 years | |
| Maria Hilado | F | 59 | 4 years | |
| Mark W. Durand | M | 64 | 17 years | |
| David J. Helfgott | M | - | - | |
| Rahul Khara | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 81 | 81.82% |
| Canada | 11 | 11.11% |
| Australia | 7 | 7.07% |
| Denmark | 1 | 1.01% |
| Ireland | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Karen Smith
- Personal Network
